The adverse event occurred in a 35-year-old participant with no co-morbidities, who was part of Phase 1 trials. The participant was hospitalised with viral pneumonitis, a couple of days after being administered the vaccineCOVID-19 Vaccine | Bharat Biotech#39;s Covaxin reported adverse event during Phase 1 trials, trials not halted
The adverse event occurred in a 35-year-old participant with no co-morbidities, who was part of Phase 1 trials. The participant was hospitalised with viral pneumonitis, a couple of days after being administered the vaccine
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment